Back To: Home




July 20 - August 2, 2014

July 27-31, 2014

More Events
Name:
Company:
Email:
 
 
 

Personalized medicine market exceeds $28 billion
April 2012
SHARING OPTIONS:

NEW YORK—Kalorama Information noted in a recent report that the personalized medicine testing market surpassed $28 billion in 2011. Tests for personalized medicine continue to gain popularity, especially in oncology, where many new medicines come paired with diagnostic assays. The tests are most popular in this area given the need to determine ideal methods of treatment individually and improve survival rates for patients. Tissue tests, such as immunohistochemical stains and in-situ hybridization, that determine which therapy to pursue for cancer treatment are what have been turning personalized medicine into a reality, the report notes. These tests are expected to experience better-than-average IVD industry revenue growth rates in the next five years. Kalorama listed Abbott Diagnostics, Dako and Roche/Ventana Medical as the market leaders in pharmacodiagnostic histology.

Back








CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.